Articles by Chris Anderson

Three-year collaboration between TTP Labtech and AZ yields custom screening solution—and an order for a second unit

Building on a years-long relationship and a recent equity investment, Waters acquires SFC specialist Thar Instruments

Millipore acquires Guava Technologies to further strengthen its position in the flow cytometry market

VistaGen, Capsant merge stem cells, cell culture and measurement tools for new screening platform

LabAutomation 2009 doesn’t skip a beat with strong year-opening event

Companies will combine Cisbio’s HTRF with BioTrove’s RapidFire mass spec platform

Hamilton, GCS collaboration yields high-density cell culture product

Heading for LabAutomation 2009 in Palm Springs, I was sure I would get a pulse on what folks in the industry felt about the financial crisis. But if I went with plenty of questions, I probably came back with a whole bunch more.

Endo Pharmaceuticals announced earlier this month that it entered into a merger agreement with Indevus Pharmaceuticals for $4.50 per share or $370 million in cash.

CambridgeSoft and StatSoft seek to join enterprise-wide data management with data mining and analytics

Chiral Technologies broadens enantiomeric separations portfolio with acquisition of ChromTech Ltd.

ALA launches LabAutopedia online automation reference guide

Roughly seven months after making a second $20 million investment in Isis Pharmaceuticals subsidiary Ibis Biosciences, Abbott announced in December that it would exercise its option to buy the remaining 81.4 percent of the company for an additional $175 million, bringing the total enterprise price to $215 million.

GSK inks aptamer deal focused on inflammatory disease that could net Archemix $1.4 billion

I’ve never been one to make New Year’s resolutions, but I do see the very beginning of the year as a time to take a look back at what I have accomplished, look forward to the possibilities of a new year and remind myself of the things that are important in this life.